サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1426855

抗がん剤の世界市場：2024年

Global Anticancer Drugs Market Research Report 2024
出版日: | 発行: QYResearch | ページ情報: 英文 180 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
抗がん剤の世界市場：2024年
出版日: 2024年02月18日
発行: QYResearch
ページ情報: 英文 180 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗がん剤の市場規模は、2023年に1,900億1,200万米ドルとなりました。

同市場は、2024年～2030年の予測期間中に11.26％のCAGRで拡大し、2030年には3,910億300万米ドルに達すると予測されています。

北米の抗がん剤の市場規模は、2023年の1,048億3,500万米ドルから2030年には2,070億6,800万米ドルに達すると予測され、2024年から2030年の予測期間中のCAGRは10.7%になると見込まれています。

アジア太平洋の抗がん剤の市場規模は、2023年の395億1,800万米ドルから2030年には890億4,200万米ドルに達すると予測され、2024年から2030年までの予測期間中のCAGRは12.38%になると見込まれています。

抗がん剤の世界の主要メーカーには、Merck & Co、Bristol-Myers Squibb、Roche、Novartis、Johnson & Johnson、AstraZeneca、Pfizer、Amgen、Eli Lillyなどがあります。2023年、世界の上位5社の売上高シェアは約55.06%でした。

当レポートでは、世界の抗がん剤市場について調査し、市場の概要とともに、企業別、タイプ別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 抗がん剤市場概要

  • 製品の定義
  • 抗がん剤、タイプ別
  • 抗がん剤、用途別
  • 世界の抗がん剤市場規模予測
  • 前提と制限

第2章 メーカーによる抗がん剤市場競争

第3章 世界の抗がん剤市場シナリオ、地域別

  • 世界の抗がん剤市場規模：2019年対2023年対2030年、地域別
  • 地域別の世界の抗がん剤収益：2019年～2030年
  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第4章 タイプ別セグメント

  • 世界の抗がん剤収益（2019年～2024年）、タイプ別
  • 世界の抗がん剤収益（2025年～2030年）、タイプ別
  • 世界の抗がん剤収益市場シェア（2019年～2030年）、タイプ別

第5章 用途別セグメント

  • 世界の抗がん剤収益（2019年～2024年）、用途別
  • 世界の抗がん剤収益（2025年～2030年）、用途別
  • 世界の抗がん剤収益市場シェア（2019年～2030年）、用途別

第6章 主要企業のプロファイル

  • Abbvie
  • Johnson & Johnson
  • Novartis
  • Gilead Sciences
  • Roche
  • Bristol-Myers Squibb
  • Amgen
  • AstraZeneca
  • Merck & Co
  • Takeda
  • Merck KGaA
  • Seagen
  • Eli Lilly
  • Ono Pharmaceutical
  • Pfizer
  • GSK
  • Exelixis
  • Regeneron
  • Innovent
  • Innovent

第7章 産業チェーンと販売チャネルの分析

  • 抗がん剤産業チェーン分析
  • 抗がん剤の主要原料
  • 抗がん剤の製造方法とプロセス
  • 抗がん剤の販売およびマーケティング
  • 抗がん剤の顧客

第8章 抗がん剤市場力学

  • 抗がん剤業界の動向
  • 抗がん剤市場の促進要因
  • 抗がん剤市場の課題
  • 抗がん剤市場の抑制要因

第9章 調査結果と結論

第10章 調査手法とデータソース

図表

List of Tables

  • Table 1. Global Anticancer Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
  • Table 2. Global Anticancer Drugs Market Value by Application (2024-2030) & (US$ Million)
  • Table 3. Global Anticancer Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
  • Table 4. Global Anticancer Drugs Revenue Share by Manufacturers (2019-2024)
  • Table 5. Global Key Players of Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
  • Table 6. Global Key Manufacturers of Anticancer Drugs, Market Area & Headquarters
  • Table 7. Global Key Manufacturers of Anticancer Drugs, Product Type
  • Table 8. Global Key Manufacturers of Anticancer Drugs, Founded Date
  • Table 9. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 10. Global Anticancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticancer Drugs as of 2023)
  • Table 11. Manufacturers Mergers & Acquisitions, Expansion Plans
  • Table 12. Global Anticancer Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
  • Table 13. Global Anticancer Drugs Revenue by Region (2019-2024) & (US$ Million)
  • Table 14. Global Anticancer Drugs Revenue Market Share by Region (2019-2024)
  • Table 15. Global Anticancer Drugs Revenue by Region (2025-2030) & (US$ Million)
  • Table 16. Global Anticancer Drugs Revenue Market Share by Region (2025-2030)
  • Table 17. North America Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 18. North America Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)
  • Table 19. North America Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)
  • Table 20. Europe Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 21. Europe Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)
  • Table 22. Europe Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)
  • Table 23. Asia Pacific Anticancer Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 24. Asia Pacific Anticancer Drugs Revenue by Region (2019-2024) & (US$ Million)
  • Table 25. Asia Pacific Anticancer Drugs Revenue by Region (2025-2030) & (US$ Million)
  • Table 26. South America Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 27. South America Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)
  • Table 28. South America Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)
  • Table 29. Middle East and Africa Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 30. Middle East and Africa Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)
  • Table 31. Middle East and Africa Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)
  • Table 32. Global Anticancer Drugs Revenue (US$ Million) by Type (2019-2024)
  • Table 33. Global Anticancer Drugs Revenue (US$ Million) by Type (2025-2030)
  • Table 34. Global Anticancer Drugs Revenue Market Share by Type (2019-2024)
  • Table 35. Global Anticancer Drugs Revenue Market Share by Type (2025-2030)
  • Table 36. Global Anticancer Drugs Revenue (US$ Million) by Application (2019-2024)
  • Table 37. Global Anticancer Drugs Revenue (US$ Million) by Application (2025-2030)
  • Table 38. Global Anticancer Drugs Revenue Market Share by Application (2019-2024)
  • Table 39. Global Anticancer Drugs Revenue Market Share by Application (2025-2030)
  • Table 40. Abbvie Company Information, Head Office, and Major Competitors
  • Table 41. Abbvie Major Business
  • Table 42. Abbvie Anticancer Drugs Product and Solutions
  • Table 43. Abbvie Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 44. Abbvie Recent Developments and Future Plans
  • Table 45. Johnson & Johnson Company Information, Head Office, and Major Competitors
  • Table 46. Johnson & Johnson Major Business
  • Table 47. Johnson & Johnson Anticancer Drugs Product and Solutions
  • Table 48. Johnson & Johnson Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 49. Johnson & Johnson Recent Developments and Future Plans
  • Table 50. Novartis Company Information, Head Office, and Major Competitors
  • Table 51. Novartis Major Business
  • Table 52. Novartis Anticancer Drugs Product and Solutions
  • Table 53. Novartis Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 54. Novartis Recent Developments and Future Plans
  • Table 55. Gilead Sciences Company Information, Head Office, and Major Competitors
  • Table 56. Gilead Sciences Major Business
  • Table 57. Gilead Sciences Anticancer Drugs Product and Solutions
  • Table 58. Gilead Sciences Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 59. Gilead Sciences Recent Developments and Future Plans
  • Table 60. Roche Company Information, Head Office, and Major Competitors
  • Table 61. Roche Major Business
  • Table 62. Roche Anticancer Drugs Product and Solutions
  • Table 63. Roche Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 64. Roche Recent Developments and Future Plans
  • Table 65. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
  • Table 66. Bristol-Myers Squibb Major Business
  • Table 67. Bristol-Myers Squibb Anticancer Drugs Product and Solutions
  • Table 68. Bristol-Myers Squibb Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 69. Bristol-Myers Squibb Recent Developments and Future Plans
  • Table 70. Amgen Company Information, Head Office, and Major Competitors
  • Table 71. Amgen Major Business
  • Table 72. Amgen Anticancer Drugs Product and Solutions
  • Table 73. Amgen Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 74. Amgen Recent Developments and Future Plans
  • Table 75. AstraZeneca Company Information, Head Office, and Major Competitors
  • Table 76. AstraZeneca Major Business
  • Table 77. AstraZeneca Anticancer Drugs Product and Solutions
  • Table 78. AstraZeneca Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 79. AstraZeneca Recent Developments and Future Plans
  • Table 80. Merck & Co Company Information, Head Office, and Major Competitors
  • Table 81. Merck & Co Major Business
  • Table 82. Merck & Co Anticancer Drugs Product and Solutions
  • Table 83. Merck & Co Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 84. Takeda Company Information, Head Office, and Major Competitors
  • Table 85. Takeda Major Business
  • Table 86. Takeda Anticancer Drugs Product and Solutions
  • Table 87. Takeda Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 88. Takeda Recent Developments and Future Plans
  • Table 89. Merck KGaA Company Information, Head Office, and Major Competitors
  • Table 90. Merck KGaA Major Business
  • Table 91. Merck KGaA Anticancer Drugs Product and Solutions
  • Table 92. Merck KGaA Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 93. Merck KGaA Recent Developments and Future Plans
  • Table 94. Seagen Company Information, Head Office, and Major Competitors
  • Table 95. Seagen Major Business
  • Table 96. Seagen Anticancer Drugs Product and Solutions
  • Table 97. Seagen Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 98. Seagen Recent Developments and Future Plans
  • Table 99. Eli Lilly Company Information, Head Office, and Major Competitors
  • Table 100. Eli Lilly Major Business
  • Table 101. Eli Lilly Anticancer Drugs Product and Solutions
  • Table 102. Eli Lilly Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 103. Ono Pharmaceutical Company Information, Head Office, and Major Competitors
  • Table 104. Ono Pharmaceutical Major Business
  • Table 105. Ono Pharmaceutical Anticancer Drugs Product and Solutions
  • Table 106. Ono Pharmaceutical Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 107. Ono Pharmaceutical Recent Developments and Future Plans
  • Table 108. Pfizer Company Information, Head Office, and Major Competitors
  • Table 109. Pfizer Major Business
  • Table 110. Pfizer Anticancer Drugs Product and Solutions
  • Table 111. Pfizer Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 112. Pfizer Recent Developments and Future Plans
  • Table 113. GSK Company Information, Head Office, and Major Competitors
  • Table 114. GSK Major Business
  • Table 115. GSK Anticancer Drugs Product and Solutions
  • Table 116. GSK Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 117. GSK Recent Developments and Future Plans
  • Table 118. Exelixis Company Information, Head Office, and Major Competitors
  • Table 119. Exelixis Major Business
  • Table 120. Exelixis Anticancer Drugs Product and Solutions
  • Table 121. Exelixis Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 122. Exelixis Recent Developments and Future Plans
  • Table 123. Regeneron Company Information, Head Office, and Major Competitors
  • Table 124. Regeneron Major Business
  • Table 125. Regeneron Anticancer Drugs Product and Solutions
  • Table 126. Regeneron Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 127. Innovent Company Information, Head Office, and Major Competitors
  • Table 128. Innovent Major Business
  • Table 129. Innovent Anticancer Drugs Product and Solutions
  • Table 130. Innovent Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 131. Hengrui Medicine Company Information, Head Office, and Major Competitors
  • Table 132. Hengrui Medicine Major Business
  • Table 133. Hengrui Medicine Anticancer Drugs Product and Solutions
  • Table 134. Hengrui Medicine Anticancer Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
  • Table 135. Key Raw Materials Lists
  • Table 136. Raw Materials Key Suppliers Lists
  • Table 137. Anticancer Drugs Distributors List
  • Table 138. Anticancer Drugs Customers List
  • Table 139. Anticancer Drugs Market Trends
  • Table 140. Anticancer Drugs Market Drivers
  • Table 141. Anticancer Drugs Market Challenges
  • Table 142. Anticancer Drugs Market Restraints
  • Table 143. Research Programs/Design for This Report
  • Table 144. Key Data Information from Secondary Sources
  • Table 145. Key Data Information from Primary Sources
  • Table 146. Authors List of This Report

List of Figures

  • Figure 1. Product Picture of Anticancer Drugs
  • Figure 2. Global Anticancer Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
  • Figure 3. Global Anticancer Drugs Market Share by Type: 2023
  • Figure 4. Global Anticancer Drugs Market Share by Type: 2030
  • Figure 5. Chemotherapy Product Picture
  • Figure 6. Targeted Therapy Product Picture
  • Figure 7. Cancer Immunotherapy Product Picture
  • Figure 8. Global Anticancer Drugs Market Value by Application (2024-2030) & (US$ Million)
  • Figure 9. Global Anticancer Drugs Market Share by Application: 2023
  • Figure 10. Global Anticancer Drugs Market Share by Application: 2030
  • Figure 11. Lung Cancer
  • Figure 12. Breast Cancer
  • Figure 13. Prostate Cancer
  • Figure 14. Blood-related Cancer
  • Figure 15. Global Anticancer Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
  • Figure 16. Global Anticancer Drugs Market Size (2019-2030) & (US$ Million)
  • Figure 17. Anticancer Drugs Report Years Considered
  • Figure 18. Global Anticancer Drugs Revenue Share by Manufacturers in 2023
  • Figure 19. Global 5 Largest Anticancer Drugs Players: Market Share by Revenue in Anticancer Drugs in 2023
  • Figure 20. Global 10 Largest Anticancer Drugs Players: Market Share by Revenue in Anticancer Drugs in 2023
  • Figure 21. Global Anticancer Drugs Market Size by Region (US$ Million): 2019-2030
  • Figure 22. North America Anticancer Drugs Revenue Market Share by Country (2019-2030)
  • Figure 23. U.S. Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 24. Canada Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 25. Mexico Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 26. Europe Anticancer Drugs Revenue Market Share by Country (2019-2030)
  • Figure 27. Germany Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 28. France Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 29. U.K. Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 30. Italy Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 31. Russia Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 32. Asia Pacific Anticancer Drugs Revenue Market Share by Region (2019-2030)
  • Figure 33. China Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 34. Japan Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 35. South Korea Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 36. India Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 37. Australia Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 38. Southeast Asia Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 39. Brazil Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 40. Middle East and Africa Anticancer Drugs Revenue Market Share by Country (2019-2030)
  • Figure 41. Middle East Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 42. Africa Anticancer Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 43. Global Revenue Market Share of Anticancer Drugs by Type (2019-2030)
  • Figure 44. Global Revenue Market Share of Anticancer Drugs by Application (2019-2030)
  • Figure 45. Merck & Co Recent Developments and Future Plans
  • Figure 46. Anticancer Drugs Value Chain
  • Figure 47. Anticancer Drugs Production Process (Capsule)
  • Figure 48. Anticancer Drugs Production Process (Injection)
  • Figure 49. Anticancer Drugs Production Process (Tablet)
  • Figure 50. Channels of Distribution (Direct Vs Distribution)
  • Figure 51. Bottom-up and Top-down Approaches for This Report
  • Figure 52. Data Triangulation
  • Figure 53. Key Executives Interviewed
目次

The global Anticancer Drugs market was valued at US$ 190,012 million in 2023 and is anticipated to reach US$ 391,003 million by 2030, witnessing a CAGR of 11.26% during the forecast period 2024-2030.

North American market for Anticancer Drugs is estimated to increase from $ 104,835 million in 2023 to reach $ 207,068 million by 2030, at a CAGR of 10.7% during the forecast period of 2024 through 2030.

Asia-Pacific market for Anticancer Drugs is estimated to increase from $ 39,518 million in 2023 to reach $ 89,042 million by 2030, at a CAGR of 12.38% during the forecast period of 2024 through 2030.

The global key manufacturers of Anticancer Drugs include Merck & Co, Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, AstraZeneca, Pfizer, Amgen, Eli Lilly, etc. In 2023, the global top five players had a share approximately 55.06% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Anticancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticancer Drugs.

The Anticancer Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticancer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anticancer Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • AbbVie
  • Johnson & Johnson
  • Novartis
  • Gilead Sciences
  • Roche
  • Bristol-Myers Squibb
  • Amgen
  • AstraZeneca
  • Merck & Co
  • Takeda
  • Merck KGaA
  • Seagen
  • Eli Lilly
  • Ono Pharmaceutical
  • Pfizer
  • GSK
  • Exelixis
  • Regeneron
  • Innovent
  • Hengrui Medicine

Segment by Type

  • Chemotherapy
  • Targeted Therapy
  • Cancer Immunotherapy
  • Other

Segment by Application

  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Blood-related Cancer
  • Other

Consumption by Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Southeast Asia
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Rest of Europe
  • South America
  • Brazil
  • Middle East & Africa
  • Middle East
  • Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Anticancer Drugs manufacturers competitive landscape revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Revenue of Anticancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Table of Contents

1 Anticancer Drugs Market Overview

  • 1.1 Product Definition
  • 1.2 Anticancer Drugs by Type
    • 1.2.1 Global Anticancer Drugs Market Value Comparison by Type (2024-2030)
    • 1.2.2 Chemotherapy
    • 1.2.3 Targeted Therapy
    • 1.2.4 Cancer Immunotherapy
  • 1.3 Anticancer Drugs by Application
    • 1.3.1 Global Anticancer Drugs Market Value by Application (2024-2030)
    • 1.3.2 Lung Cancer
    • 1.3.3 Breast Cancer
    • 1.3.4 Prostate Cancer
    • 1.3.5 Blood-related Cancer
  • 1.4 Global Anticancer Drugs Market Size Estimates and Forecasts
  • 1.5 Assumptions and Limitations

2 Anticancer Drugs Market Competition by Manufacturers

  • 2.1 Global Anticancer Drugs Revenue Market Share by Manufacturers (2019-2024)
  • 2.2 Global Key Players of Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
  • 2.3 Global Key Manufacturers of Anticancer Drugs, Market Area & Headquarters
  • 2.4 Global Key Manufacturers of Anticancer Drugs, Product Type
  • 2.5 Global Key Manufacturers of Anticancer Drugs, Founded Date
  • 2.6 Global Anticancer Drugs Market Competitive Situation and Trends
    • 2.6.1 Global Anticancer Drugs Market Concentration Rate
    • 2.6.2 The Global 5 and 10 Largest Anticancer Drugs Players Market Share by Revenue
    • 2.6.3 Global Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 2.7 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Anticancer Drugs Market Scenario by Region

  • 3.1 Global Anticancer Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
  • 3.2 Global Anticancer Drugs Revenue by Region: 2019-2030
    • 3.2.1 Global Anticancer Drugs Revenue by Region: 2019-2024
    • 3.2.2 Global Anticancer Drugs Revenue by Region: 2025-2030
  • 3.3 North America Anticancer Drugs Market Facts & Figures by Country
    • 3.3.1 North America Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
    • 3.3.2 North America Anticancer Drugs Revenue by Country (2019-2030)
    • 3.3.3 U.S.
    • 3.3.4 Canada
    • 3.3.5 Mexico
  • 3.4 Europe Anticancer Drugs Market Facts & Figures by Country
    • 3.4.1 Europe Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
    • 3.4.2 Europe Anticancer Drugs Revenue by Country (2019-2030)
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Anticancer Drugs Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Anticancer Drugs Market Size by Region: 2019 VS 2023 VS 2030
    • 3.5.2 Asia Pacific Anticancer Drugs Revenue by Region (2019-2030)
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Southeast Asia
  • 3.6 South America Anticancer Drugs Market Facts & Figures by Country
    • 3.6.1 South America Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
    • 3.6.2 South America Anticancer Drugs Revenue by Country
    • 3.6.3 Brazil
  • 3.7 Middle East and Africa Anticancer Drugs Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Anticancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
    • 3.7.2 Middle East and Africa Anticancer Drugs Revenue by Country
    • 3.7.3 Middle East
    • 3.7.4 Africa

4 Segment by Type

  • 4.1 Global Anticancer Drugs Revenue by Type (2019-2024)
  • 4.2 Global Anticancer Drugs Revenue by Type (2025-2030)
  • 4.3 Global Anticancer Drugs Revenue Market Share by Type (2019-2030)

5 Segment by Application

  • 5.1 Global Anticancer Drugs Revenue by Application (2019-2024)
  • 5.2 Global Anticancer Drugs Revenue by Application (2025-2030)
  • 5.3 Global Anticancer Drugs Revenue Market Share by Application (2019-2030)

6 Key Companies Profiled

  • 6.1 Abbvie
    • 6.1.1 Abbvie Details
    • 6.1.2 Abbvie Major Business
    • 6.1.3 Abbvie Anticancer Drugs Product and Solutions
    • 6.1.4 Abbvie Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.1.5 Abbvie Recent Developments and Future Plans
  • 6.2 Johnson & Johnson
    • 6.2.1 Johnson & Johnson Details
    • 6.2.2 Johnson & Johnson Major Business
    • 6.2.3 Johnson & Johnson Anticancer Drugs Product and Solutions
    • 6.2.4 Johnson & Johnson Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.2.5 Johnson & Johnson Recent Developments and Future Plans
  • 6.3 Novartis
    • 6.3.1 Novartis Details
    • 6.3.2 Novartis Major Business
    • 6.3.3 Novartis Anticancer Drugs Product and Solutions
    • 6.3.4 Novartis Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.3.5 Novartis Recent Developments and Future Plans
  • 6.4 Gilead Sciences
    • 6.4.1 Gilead Sciences Details
    • 6.4.2 Gilead Sciences Major Business
    • 6.4.3 Gilead Sciences Anticancer Drugs Product and Solutions
    • 6.4.4 Gilead Sciences Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.4.5 Gilead Sciences Recent Developments and Future Plans
  • 6.5 Roche
    • 6.5.1 Roche Details
    • 6.5.2 Roche Major Business
    • 6.5.3 Roche Anticancer Drugs Product and Solutions
    • 6.5.4 Roche Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.5.5 Roche Recent Developments and Future Plans
  • 6.6 Bristol-Myers Squibb
    • 6.6.1 Bristol-Myers Squibb Details
    • 6.6.2 Bristol-Myers Squibb Major Business
    • 6.6.3 Bristol-Myers Squibb Anticancer Drugs Product and Solutions
    • 6.6.4 Bristol-Myers Squibb Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 6.7 Amgen
    • 6.7.1 Amgen Details
    • 6.7.2 Amgen Major Business
    • 6.7.3 Amgen Anticancer Drugs Product and Solutions
    • 6.7.4 Amgen Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.7.5 Amgen Recent Developments and Future Plans
  • 6.8 AstraZeneca
    • 6.8.1 AstraZeneca Details
    • 6.8.2 AstraZeneca Major Business
    • 6.8.3 AstraZeneca Anticancer Drugs Product and Solutions
    • 6.8.4 AstraZeneca Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.8.5 AstraZeneca Recent Developments and Future Plans
  • 6.9 Merck & Co
    • 6.9.1 Merck & Co Details
    • 6.9.2 Merck & Co Major Business
    • 6.9.3 Merck & Co Anticancer Drugs Product and Solutions
    • 6.9.4 Merck & Co Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.9.5 Merck & Co Recent Developments and Future Plans
  • 6.10 Takeda
    • 6.10.1 Takeda Details
    • 6.10.2 Takeda Major Business
    • 6.10.3 Takeda Anticancer Drugs Product and Solutions
    • 6.10.4 Takeda Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.10.5 Takeda Recent Developments and Future Plans
  • 6.11 Merck KGaA
    • 6.11.1 Merck KGaA Details
    • 6.11.2 Merck KGaA Major Business
    • 6.11.3 Merck KGaA Anticancer Drugs Product and Solutions
    • 6.11.4 Merck KGaA Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.11.5 Merck KGaA Recent Developments and Future Plans
  • 6.12 Seagen
    • 6.12.1 Seagen Details
    • 6.12.2 Seagen Major Business
    • 6.12.3 Seagen Anticancer Drugs Product and Solutions
    • 6.12.4 Seagen Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.12.5 Seagen Recent Developments and Future Plans
  • 6.13 Eli Lilly
    • 6.13.1 Eli Lilly Details
    • 6.13.2 Eli Lilly Major Business
    • 6.13.3 Eli Lilly Anticancer Drugs Product and Solutions
    • 6.13.4 Eli Lilly Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
  • 6.14 Ono Pharmaceutical
    • 6.14.1 Ono Pharmaceutical Details
    • 6.14.2 Ono Pharmaceutical Major Business
    • 6.14.3 Ono Pharmaceutical Anticancer Drugs Product and Solutions
    • 6.14.4 Ono Pharmaceutical Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.14.5 Ono Pharmaceutical Recent Developments and Future Plans
  • 6.15 Pfizer
    • 6.15.1 Pfizer Details
    • 6.15.2 Pfizer Major Business
    • 6.15.3 Pfizer Anticancer Drugs Product and Solutions
    • 6.15.4 Pfizer Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.15.5 Pfizer Recent Developments and Future Plans
  • 6.16 GSK
    • 6.16.1 GSK Details
    • 6.16.2 GSK Major Business
    • 6.16.3 GSK Anticancer Drugs Product and Solutions
    • 6.16.4 GSK Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.16.5 GSK Recent Developments and Future Plans
  • 6.17 Exelixis
    • 6.17.1 Exelixis Details
    • 6.17.2 Exelixis Major Business
    • 6.17.3 Exelixis Anticancer Drugs Product and Solutions
    • 6.17.4 Exelixis Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 6.17.5 Exelixis Recent Developments and Future Plans
  • 6.18 Regeneron
    • 6.18.1 Regeneron Details
    • 6.18.2 Regeneron Major Business
    • 6.18.3 Regeneron Anticancer Drugs Product and Solutions
    • 6.18.4 Regeneron Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
  • 6.19 Innovent
    • 6.19.1 Innovent Details
    • 6.19.2 Innovent Major Business
    • 6.19.3 Innovent Anticancer Drugs Product and Solutions
    • 6.19.4 Innovent Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
  • 6.20 Hengrui Medicine
    • 6.20.1 Hengrui Medicine Details
    • 6.20.2 Hengrui Medicine Major Business
    • 6.20.3 Hengrui Medicine Anticancer Drugs Product and Solutions
    • 6.20.4 Hengrui Medicine Anticancer Drugs Revenue, Gross Margin and Market Share (2019-2024)

7 Industry Chain and Sales Channels Analysis

  • 7.1 Anticancer Drugs Industry Chain Analysis
  • 7.2 Anticancer Drugs Key Raw Materials
    • 7.2.1 Key Raw Materials
    • 7.2.2 Raw Materials Key Suppliers
  • 7.3 Anticancer Drugs Production Mode & Process
  • 7.4 Anticancer Drugs Sales and Marketing
    • 7.4.1 Anticancer Drugs Sales Channels
    • 7.4.2 Anticancer Drugs Distributors
  • 7.5 Anticancer Drugs Customers

8 Anticancer Drugs Market Dynamics

  • 8.1 Anticancer Drugs Industry Trends
  • 8.2 Anticancer Drugs Market Drivers
  • 8.3 Anticancer Drugs Market Challenges
  • 8.4 Anticancer Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

  • 10.1 Methodology/Research Approach
    • 10.1.1 Research Programs/Design
    • 10.1.2 Market Size Estimation
    • 10.1.3 Market Breakdown and Data Triangulation
  • 10.2 Data Source
    • 10.2.1 Secondary Sources
    • 10.2.2 Primary Sources
  • 10.3 Author List
  • 10.4 Disclaimer